Clopidogrel or Ticagrelor: Why, When, for Whom?

Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor, is the cornerstone of the management of acute coronary syndromes. Despite its proven benefits, the choice of P2Y12 inhibitors remains to be debated over the decades because of the differences in efficacy and safety profiles among these agents. In this 60-minute session by the […]

Nebivolol: No limb pain?

Beta-blockers are routinely prescribed often as first-line therapy for various cardiovascular diseases such as coronary heart disease and heart failure. Much of their prescribing relates to the benefits of the newer generation of beta-blockers and greater cardio-selectivity. One of the challenges all clinicians face is to manage the choice of numerous beta-blockers and in particular […]

Digitalising Care for Hypertension: One for All, All for One

Live webinar on Wednesday 8th May 2024 @13.30 BST And we are back with our second session of 2024! Join us for an insightful 1-hour LIVE webinar on revolutionising hypertension care through digital health solutions. Gain valuable insights from leading experts on how digital tools empower both healthcare professionals and patients to effectively tackle hypertension, […]